Literature DB >> 27584676

Comparison Between Minimally Invasive Surgery and Conventional Open Surgery for Patients With Spinal Metastasis: A Prospective Propensity Score-Matched Study.

Nils Hansen-Algenstaedt1, Mun Keong Kwan, Petra Algenstaedt, Chee Kidd Chiu, Lennart Viezens, Teik Seng Chan, Chee Kean Lee, Jasmin Wellbrock, Chris Yin Wei Chan, Christian Schaefer.   

Abstract

STUDY
DESIGN: Prospective propensity score-matched study.
OBJECTIVE: To compare the outcomes of minimal invasive surgery (MIS) and conventional open surgery for spinal metastasis patients. SUMMARY OF BACKGROUND DATA: There is lack of knowledge on whether MIS is comparable to conventional open surgery in treating spinal metastasis.
METHODS: Patients with spinal metastasis requiring surgery from January 2008 to December 2010 in two spine centers were recruited. The demographic, preoperative, operative, perioperative and postoperative data were collected and analyzed. Thirty MIS patients were matched with 30 open surgery patients using propensity score matching technique with a match tolerance of 0.02 based on the covariate age, tumor type, Tokuhashi score, and Tomita score.
RESULTS: Both groups had significant improvements in Eastern Cooperative Oncology Group (ECOG), Karnofsky scores, visual analogue scale (VAS) for pain and neurological status postoperatively. However, the difference comparing the MIS and open surgery group was not statistically significant. MIS group had significantly longer instrumented segments (5.5 ± 3.1) compared with open group (3.8 ± 1.7). Open group had significantly longer decompressed segment (1.8 ± 0.8) than MIS group (1.0 ± 1.0). Open group had significantly more blood loss (2062.1 ± 1148.0 mL) compared with MIS group (1156.0 ± 572.3 mL). More patients in the open group (76.7%) needed blood transfusions (with higher average units of blood transfused) compared with MIS group (40.0%). Fluoroscopy time was significantly longer in MIS group (116.1 ± 63.3 s) compared with open group (69.9 ± 42.6 s). Open group required longer hospitalization (21.1 ± 10.8 days) compared with MIS group (11.0 ± 5.0 days).
CONCLUSION: This study demonstrated that MIS resulted in comparable outcome to open surgery for patients with spinal metastasis but has the advantage of less blood loss, blood transfusions, and shorter hospital stay. LEVEL OF EVIDENCE: 3.

Entities:  

Mesh:

Year:  2017        PMID: 27584676     DOI: 10.1097/BRS.0000000000001893

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  18 in total

Review 1.  Minimally invasive versus conventional spine surgery for vertebral metastases: a systematic review of the evidence.

Authors:  Zach Pennington; A Karim Ahmed; Camilo A Molina; Jeffrey Ehresman; Ilya Laufer; Daniel M Sciubba
Journal:  Ann Transl Med       Date:  2018-03

Review 2.  [Management of osseous complications in multiple myeloma].

Authors:  K Zarghooni; S Hopf; P Eysel
Journal:  Internist (Berl)       Date:  2019-01       Impact factor: 0.743

3.  Minimal Access Surgery for Spinal Metastases: Prospective Evaluation of a Treatment Algorithm Using Patient-Reported Outcomes.

Authors:  Ori Barzilai; Lily McLaughlin; Mary-Kate Amato; Anne S Reiner; Shahiba Q Ogilvie; Eric Lis; Yoshiya Yamada; Mark H Bilsky; Ilya Laufer
Journal:  World Neurosurg       Date:  2018-09-04       Impact factor: 2.104

4.  Comparison between minimally invasive spine stabilization with and without posterior decompression for the management of spinal metastases: a retrospective cohort study.

Authors:  Hiroshi Uei; Yasuaki Tokuhashi; Masafumi Maseda; Masahiro Nakahashi; Hirokatsu Sawada; Enshi Nakayama; Hirotoki Soma
Journal:  J Orthop Surg Res       Date:  2018-04-16       Impact factor: 2.359

5.  Clinical Results of Minimally Invasive Spine Stabilization for the Management of Metastatic Spinal Tumors Based on the Epidural Spinal Cord Compression Scale.

Authors:  Hiroshi Uei; Yasuaki Tokuhashi; Masafumi Maseda; Masahiro Nakahashi; Hirokatsu Sawada; Koji Matsumoto; Hiroyuki Miyakata; Hirotoki Soma
Journal:  Biomed Res Int       Date:  2018-11-08       Impact factor: 3.411

6.  [Usefulness of minimally invasive spine surgery for the management of thoracolumbar spinal metastases].

Authors:  Santiago Hem; Sofía Beltrame; Jorge Rasmussen; Eduardo Vecchi; Federico Landriel; Claudio Yampolsky
Journal:  Surg Neurol Int       Date:  2019-02-15

7.  Therapeutic Impact of Percutaneous Pedicle Screw Fixation on Palliative Surgery for Metastatic Spine Tumors.

Authors:  Hiroshi Uei; Yasuaki Tokuhashi
Journal:  Indian J Orthop       Date:  2019 Jul-Aug       Impact factor: 1.251

8.  Essential Concepts for the Management of Metastatic Spine Disease: What the Surgeon Should Know and Practice.

Authors:  Ori Barzilai; Stefano Boriani; Charles G Fisher; Arjun Sahgal; Jorrit Jan Verlaan; Ziya L Gokaslan; Aron Lazary; Chetan Bettegowda; Laurence D Rhines; Ilya Laufer
Journal:  Global Spine J       Date:  2019-05-08

Review 9.  Decision Making in Patients With Metastatic Spine. The Role of Minimally Invasive Treatment Modalities.

Authors:  Alfredo Conti; Güliz Acker; Anne Kluge; Franziska Loebel; Anita Kreimeier; Volker Budach; Peter Vajkoczy; Ilaria Ghetti; Antonino F Germano'; Carolin Senger
Journal:  Front Oncol       Date:  2019-09-19       Impact factor: 6.244

10.  The Role of Minimal Access Surgery in the Treatment of Spinal Metastatic Tumors.

Authors:  Ori Barzilai; Mark H Bilsky; Ilya Laufer
Journal:  Global Spine J       Date:  2020-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.